Drug Search Results
More Filters [+]

CJ-30001

Alternative Names: cj-30001, cj30001, cj 30001
Latest Update: 2013-02-15
Latest Update Note: Clinical Trial Update

Product Description

For Diabetes Mellitus (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01370707)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: HK inno.N
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CJ-30001

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Type 2 Diabetes

Phase 1: Healthy Volunteers|General Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CJ_VCM_301

P3

Completed

Type 2 Diabetes

2012-07-01

CJ_VCM_103

P1

Completed

General Diabetes|Healthy Volunteers

2010-02-01

CJ_VCM_102

P1

Completed

Healthy Volunteers|General Diabetes

2009-11-01

Recent News Events

Date

Type

Title